...
首页> 外文期刊>European journal of anaesthesiology >Comparison of etomidate-remifentanil and propofol-remifentanil sedation in patients scheduled for colonoscopy.
【24h】

Comparison of etomidate-remifentanil and propofol-remifentanil sedation in patients scheduled for colonoscopy.

机译:计划进行结肠镜检查的患者中依托咪酯-瑞芬太尼和丙泊酚-瑞芬太尼镇静的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of the study was to compare haemodynamic responses, recovery and discharge times, and physician satisfaction of etomidate-remifentanil and propofol-remifentanil combinations in patients undergoing elective colonoscopy. METHODS: Sixty patients, aged 18-65 years, scheduled for elective colonoscopy under sedation were prospectively randomized, double blind for the study. Two minutes after the beginning of a continuous remifentanil infusion (0.1 microg kg(-1) min(-1)), etomidate or propofol were administered. Patients in the etomidate group received a 0.05 mg kg(-1) maintenance dose of etomidate after an initial dose of 0.1 mg kg(-1), and patients in the propofol group received a 0.25 mg kg(-1) maintenance dose of propofol after an initial dose of 0.5 mg kg(-1) in order to have a Ramsay sedation score of 3-4. Basal values of heart rate, mean arterial pressure, oxygen saturation, respiratory rate and Ramsay sedation score were recorded. Values were recorded every 2 min for the first 10 min and every 5 min thereafter, until the completion of the procedure. RESULTS: Mean arterial pressure was lower at 4, 6, 8, 10, 15, 20 and 25 min in the propofol group (P = 0.001). Mean respiratory rate in the propofol group at 6, 8, 10, 15, 20, 25 min was also lower (P < 0.05). The incidence of apnoea and hypotension was significantly lower in the etomidate group (P < 0.001). Arrival time into the postoperative care unit and recovery time were shorter in the etomidate group (P = 0.001, P = 0.01, respectively). Physician satisfaction in both groups was similar. CONCLUSION: Etomidate-remifentanil administration for sedation and analgesia during colonoscopy resulted in more stable haemodynamic responses and shorter recovery and discharge times.
机译:目的:本研究的目的是比较择期结肠镜检查患者的依托咪酯-瑞芬太尼和丙泊酚-瑞芬太尼联合用药的血液动力学反应,恢复和出院时间以及医师满意度。方法:将60例年龄在18-65岁,计划在镇静下进行选择性结肠镜检查的患者随机分为双盲研究对象。开始连续瑞芬太尼输注(0.1 microg kg(-1)min(-1))两分钟后,给予依托咪酯或丙泊酚。依托咪酯组的患者在初始剂量0.1 mg kg(-1)后接受了0.05 mg kg(-1)的依托咪酯维持剂量,而丙泊酚组的患者接受了0.25 mg kg(-1)维持剂量的丙泊酚初始剂量为0.5 mg kg(-1)后,Ramsay镇静评分为3-4。记录心率,平均动脉压,血氧饱和度,呼吸频率和Ramsay镇静分数的基础值。在开始的10分钟内每2分钟记录一次值,此后每5分钟记录一次值,直到操作完成。结果:丙泊酚组在4、6、8、10、15、20和25分钟时的平均动脉压较低(P = 0.001)。丙泊酚组在6、8、10、15、20、25分钟时的平均呼吸频率也较低(P <0.05)。依托咪酯组的呼吸暂停和低血压发生率显着降低(P <0.001)。依托咪酯组进入术后护理单位的时间和恢复时间较短(分别为P = 0.001,P = 0.01)。两组的医师满意度相似。结论:依托咪酯-瑞芬太尼在结肠镜检查期间用于镇静和镇痛可导致更稳定的血液动力学反应和更短的恢复和出院时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号